Up, Up, and Away
A business analyst rated Baxter stock a strong BUY, as the PD market has an attractive growth rate in the range of 5% to 6%, and the option is flexible and allows a more normal life.
Read the full article » | Posted 07-14-2017
Related Articles
- Vantive: Real People, Real Stories on PD Empowers Site for Patients Posted 12-17-2025
- Medicare Fee Schedule Final Rule Summary: CY 2026 Posted 12-17-2025
- Medicare Deductible, Coinsurance & Premium Rates for 2026 Posted 12-17-2025
- Watch Dr. Joel Glickman’s ASN presentation on Home HD Prescriptions Posted 12-17-2025

